Scott T. Rottinghaus
Chief Medical Officer · ENANTA PHARMACEUTICALS INC
- 2024
- Aug 10, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Scott T. Rottinghaus files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jay R. Luly - $67K in ENTA purchases and sales in the last 12 months
- Yat Sun Or - $34K in ENTA purchases and sales in the last 12 months
- Tara Lynn Kieffer - $30K in ENTA purchases and sales in the last 12 months
- Brendan Luu - $20K in ENTA purchases and sales in the last 12 months
- Harry R. Trout III - $13K in ENTA purchases and sales in the last 12 months
- Kathleen S. Capps - $7K in ENTA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Scott T. Rottinghaus?
Scott T. Rottinghaus is a corporate insider, tracked as Chief Medical Officer of ENANTA PHARMACEUTICALS INC (ENTA). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Scott T. Rottinghaus submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Scott T. Rottinghaus been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($18K) across all tracked filings.
